Stearate  ||| S:0 E:9 ||| NNP
organogel-gelatin  ||| S:9 E:27 ||| NNP
hydrogel  ||| S:27 E:36 ||| VBD
based  ||| S:36 E:42 ||| VBN
bigels ||| S:42 E:48 ||| NNS
:  ||| S:48 E:50 ||| :
physicochemical ||| S:50 E:65 ||| CD
,  ||| S:65 E:67 ||| ,
thermal ||| S:67 E:74 ||| JJ
,  ||| S:74 E:76 ||| ,
mechanical  ||| S:76 E:87 ||| JJ
characterizations  ||| S:87 E:105 ||| NN
and  ||| S:105 E:109 ||| CC
in  ||| S:109 E:112 ||| IN
vitro  ||| S:112 E:118 ||| JJ
drug  ||| S:118 E:123 ||| NN
delivery  ||| S:123 E:132 ||| NN
applications  ||| S:132 E:145 ||| NNS
Over  ||| S:145 E:150 ||| IN
the  ||| S:150 E:154 ||| DT
past  ||| S:154 E:159 ||| JJ
decade ||| S:159 E:165 ||| NN
,  ||| S:165 E:167 ||| ,
researchers  ||| S:167 E:179 ||| NNS
have  ||| S:179 E:184 ||| VBP
been  ||| S:184 E:189 ||| VBN
trying  ||| S:189 E:196 ||| VBG
to  ||| S:196 E:199 ||| TO
develop  ||| S:199 E:207 ||| VB
alternative  ||| S:207 E:219 ||| JJ
gel  ||| S:219 E:223 ||| NNS
based  ||| S:223 E:229 ||| VBN
formulations  ||| S:229 E:242 ||| NNS
in  ||| S:242 E:245 ||| IN
comparison  ||| S:245 E:256 ||| NN
to  ||| S:256 E:259 ||| TO
the  ||| S:259 E:263 ||| DT
traditional  ||| S:263 E:275 ||| JJ
hydrogels  ||| S:275 E:285 ||| NN
and  ||| S:285 E:289 ||| CC
emulgels ||| S:289 E:297 ||| NN
.  ||| S:297 E:299 ||| .
In  ||| S:299 E:302 ||| IN
this  ||| S:302 E:307 ||| DT
perspective ||| S:307 E:318 ||| NN
,  ||| S:318 E:320 ||| ,
bigels  ||| S:320 E:327 ||| NN
were  ||| S:327 E:332 ||| VBD
synthesized  ||| S:332 E:344 ||| VBN
by  ||| S:344 E:347 ||| IN
mixing  ||| S:347 E:354 ||| VBG
gelatin  ||| S:354 E:362 ||| JJ
hydrogel  ||| S:362 E:371 ||| NN
and  ||| S:371 E:375 ||| CC
stearic  ||| S:375 E:383 ||| JJ
acid  ||| S:383 E:388 ||| NN
based  ||| S:388 E:394 ||| VBN
organogel  ||| S:394 E:404 ||| VBN
by  ||| S:404 E:407 ||| IN
hot  ||| S:407 E:411 ||| JJ
emulsification  ||| S:411 E:426 ||| JJ
method ||| S:426 E:432 ||| NN
.  ||| S:432 E:434 ||| .
Two  ||| S:434 E:438 ||| CD
types  ||| S:438 E:444 ||| NNS
of  ||| S:444 E:447 ||| IN
bigels  ||| S:447 E:454 ||| NN
were  ||| S:454 E:459 ||| VBD
synthesized  ||| S:459 E:471 ||| VBN
using  ||| S:471 E:477 ||| VBG
sesame  ||| S:477 E:484 ||| JJ
oil  ||| S:484 E:488 ||| NN
and  ||| S:488 E:492 ||| CC
soy  ||| S:492 E:496 ||| JJ
bean  ||| S:496 E:501 ||| JJ
oil  ||| S:501 E:505 ||| NN
based  ||| S:505 E:511 ||| VBN
stearate  ||| S:511 E:520 ||| JJ
organogels ||| S:520 E:530 ||| NN
.  ||| S:530 E:532 ||| .
Gelatin  ||| S:532 E:540 ||| RB
based  ||| S:540 E:546 ||| VBN
emulgels  ||| S:546 E:555 ||| RB
prepared  ||| S:555 E:564 ||| VBN
using  ||| S:564 E:570 ||| VBG
sesame  ||| S:570 E:577 ||| JJ
oil  ||| S:577 E:581 ||| NN
and  ||| S:581 E:585 ||| CC
soy  ||| S:585 E:589 ||| JJ
bean  ||| S:589 E:594 ||| JJ
oil  ||| S:594 E:598 ||| NN
were  ||| S:598 E:603 ||| VBD
used  ||| S:603 E:608 ||| VBN
as  ||| S:608 E:611 ||| IN
the  ||| S:611 E:615 ||| DT
controls ||| S:615 E:623 ||| NNS
.  ||| S:623 E:625 ||| .
Microscopic  ||| S:625 E:637 ||| JJ
studies  ||| S:637 E:645 ||| NNS
revealed  ||| S:645 E:654 ||| VBD
that  ||| S:654 E:659 ||| IN
the  ||| S:659 E:663 ||| DT
bigels  ||| S:663 E:670 ||| NN
contained  ||| S:670 E:680 ||| VBD
aggregates  ||| S:680 E:691 ||| NNS
of  ||| S:691 E:694 ||| IN
droplets ||| S:694 E:702 ||| NNS
,  ||| S:702 E:704 ||| ,
whereas ||| S:704 E:711 ||| NN
,  ||| S:711 E:713 ||| ,
emulgels  ||| S:713 E:722 ||| NN
showed  ||| S:722 E:729 ||| VBD
dispersed  ||| S:729 E:739 ||| JJ
droplets  ||| S:739 E:748 ||| NNS
within  ||| S:748 E:755 ||| IN
the  ||| S:755 E:759 ||| DT
continuum  ||| S:759 E:769 ||| JJ
phase ||| S:769 E:774 ||| NN
.  ||| S:774 E:776 ||| .
The  ||| S:776 E:780 ||| DT
emulgels  ||| S:780 E:789 ||| NN
showed  ||| S:789 E:796 ||| VBD
higher  ||| S:796 E:803 ||| JJR
amount  ||| S:803 E:810 ||| NN
of  ||| S:810 E:813 ||| IN
leaching  ||| S:813 E:822 ||| NN
of  ||| S:822 E:825 ||| IN
oils ||| S:825 E:829 ||| NNS
,  ||| S:829 E:831 ||| ,
whereas ||| S:831 E:838 ||| NN
,  ||| S:838 E:840 ||| ,
the  ||| S:840 E:844 ||| DT
leaching  ||| S:844 E:853 ||| NN
of  ||| S:853 E:856 ||| IN
the  ||| S:856 E:860 ||| DT
internal  ||| S:860 E:869 ||| JJ
phase  ||| S:869 E:875 ||| NN
was  ||| S:875 E:879 ||| VBD
negligible  ||| S:879 E:890 ||| VBN
from  ||| S:890 E:895 ||| IN
the  ||| S:895 E:899 ||| DT
bigels ||| S:899 E:905 ||| NN
.  ||| S:905 E:907 ||| .
Presence  ||| S:907 E:916 ||| NN
of  ||| S:916 E:919 ||| IN
organogel  ||| S:919 E:929 ||| JJ
matrix  ||| S:929 E:936 ||| NN
within  ||| S:936 E:943 ||| IN
the  ||| S:943 E:947 ||| DT
bigels  ||| S:947 E:954 ||| NN
was  ||| S:954 E:958 ||| VBD
confirmed  ||| S:958 E:968 ||| VBN
by  ||| S:968 E:971 ||| IN
XRD ||| S:971 E:974 ||| NNP
,  ||| S:974 E:976 ||| ,
FTIR  ||| S:976 E:981 ||| NNP
and  ||| S:981 E:985 ||| CC
DSC  ||| S:985 E:989 ||| NNP
methods ||| S:989 E:996 ||| NNS
.  ||| S:996 E:998 ||| .
Bigels  ||| S:998 E:1005 ||| NNP
showed  ||| S:1005 E:1012 ||| VBD
higher  ||| S:1012 E:1019 ||| JJR
mucoadhesive  ||| S:1019 E:1032 ||| NNS
and  ||| S:1032 E:1036 ||| CC
mechanical  ||| S:1036 E:1047 ||| JJ
properties  ||| S:1047 E:1058 ||| NNS
compared  ||| S:1058 E:1067 ||| VBN
to  ||| S:1067 E:1070 ||| TO
emulgels ||| S:1070 E:1078 ||| VB
.  ||| S:1078 E:1080 ||| .
Cyclic  ||| S:1080 E:1087 ||| NNP
creep-recovery  ||| S:1087 E:1102 ||| NNP
and  ||| S:1102 E:1106 ||| CC
stress  ||| S:1106 E:1113 ||| NN
relaxation  ||| S:1113 E:1124 ||| NN
studies  ||| S:1124 E:1132 ||| NNS
confirmed  ||| S:1132 E:1142 ||| VBD
the  ||| S:1142 E:1146 ||| DT
viscoelastic  ||| S:1146 E:1159 ||| JJ
nature  ||| S:1159 E:1166 ||| NN
of  ||| S:1166 E:1169 ||| IN
the  ||| S:1169 E:1173 ||| DT
formulations ||| S:1173 E:1185 ||| NN
.  ||| S:1185 E:1187 ||| .
Four  ||| S:1187 E:1192 ||| CD
elemental  ||| S:1192 E:1202 ||| JJ
Burger ||| S:1202 E:1208 ||| NNP
's  ||| S:1208 E:1211 ||| POS
model  ||| S:1211 E:1217 ||| NN
was  ||| S:1217 E:1221 ||| VBD
employed  ||| S:1221 E:1230 ||| VBN
to  ||| S:1230 E:1233 ||| TO
analyze  ||| S:1233 E:1241 ||| VB
the  ||| S:1241 E:1245 ||| DT
cyclic  ||| S:1245 E:1252 ||| JJ
creep-recovery  ||| S:1252 E:1267 ||| JJ
data ||| S:1267 E:1271 ||| NNS
.  ||| S:1271 E:1273 ||| .
Cyclic  ||| S:1273 E:1280 ||| JJ
creep-recovery  ||| S:1280 E:1295 ||| JJ
studies  ||| S:1295 E:1303 ||| NNS
suggested  ||| S:1303 E:1313 ||| VBD
that  ||| S:1313 E:1318 ||| IN
the  ||| S:1318 E:1322 ||| DT
deformation  ||| S:1322 E:1334 ||| NN
of  ||| S:1334 E:1337 ||| IN
the  ||| S:1337 E:1341 ||| DT
bigels  ||| S:1341 E:1348 ||| NN
were  ||| S:1348 E:1353 ||| VBD
lower  ||| S:1353 E:1359 ||| RBR
due  ||| S:1359 E:1363 ||| JJ
to  ||| S:1363 E:1366 ||| TO
the  ||| S:1366 E:1370 ||| DT
presence  ||| S:1370 E:1379 ||| NN
of  ||| S:1379 E:1382 ||| IN
the  ||| S:1382 E:1386 ||| DT
organogels  ||| S:1386 E:1397 ||| NN
within  ||| S:1397 E:1404 ||| IN
its  ||| S:1404 E:1408 ||| PRP$
structure ||| S:1408 E:1417 ||| NN
.  ||| S:1417 E:1419 ||| .
The  ||| S:1419 E:1423 ||| DT
formulations  ||| S:1423 E:1436 ||| NN
showed  ||| S:1436 E:1443 ||| VBD
almost  ||| S:1443 E:1450 ||| RB
100 ||| S:1450 E:1453 ||| CD
%  ||| S:1453 E:1455 ||| NN
recovery  ||| S:1455 E:1464 ||| NN
after  ||| S:1464 E:1470 ||| IN
the  ||| S:1470 E:1474 ||| DT
creep  ||| S:1474 E:1480 ||| JJ
stage  ||| S:1480 E:1486 ||| NN
and  ||| S:1486 E:1490 ||| CC
can  ||| S:1490 E:1494 ||| MD
be  ||| S:1494 E:1497 ||| VB
explained  ||| S:1497 E:1507 ||| VBN
by  ||| S:1507 E:1510 ||| IN
the  ||| S:1510 E:1514 ||| DT
higher  ||| S:1514 E:1521 ||| JJR
elastic  ||| S:1521 E:1529 ||| JJ
nature  ||| S:1529 E:1536 ||| NN
of  ||| S:1536 E:1539 ||| IN
the  ||| S:1539 E:1543 ||| DT
formulations ||| S:1543 E:1555 ||| NN
.  ||| S:1555 E:1557 ||| .
Stress  ||| S:1557 E:1564 ||| NN
relaxation  ||| S:1564 E:1575 ||| NN
study  ||| S:1575 E:1581 ||| NN
showed  ||| S:1581 E:1588 ||| VBD
that  ||| S:1588 E:1593 ||| IN
the  ||| S:1593 E:1597 ||| DT
relaxation  ||| S:1597 E:1608 ||| NN
time  ||| S:1608 E:1613 ||| NN
was  ||| S:1613 E:1617 ||| VBD
higher  ||| S:1617 E:1624 ||| JJR
in  ||| S:1624 E:1627 ||| IN
the  ||| S:1627 E:1631 ||| DT
emulgels  ||| S:1631 E:1640 ||| NN
as  ||| S:1640 E:1643 ||| IN
compared  ||| S:1643 E:1652 ||| VBN
to  ||| S:1652 E:1655 ||| TO
the  ||| S:1655 E:1659 ||| DT
bigels ||| S:1659 E:1665 ||| NN
.  ||| S:1665 E:1667 ||| .
Also ||| S:1667 E:1671 ||| RB
,  ||| S:1671 E:1673 ||| ,
the  ||| S:1673 E:1677 ||| DT
%  ||| S:1677 E:1679 ||| NN
relaxation  ||| S:1679 E:1690 ||| NN
was  ||| S:1690 E:1694 ||| VBD
higher  ||| S:1694 E:1701 ||| JJR
in  ||| S:1701 E:1704 ||| IN
emulgels  ||| S:1704 E:1713 ||| NNS
suggesting  ||| S:1713 E:1724 ||| VBG
its  ||| S:1724 E:1728 ||| PRP$
fluid  ||| S:1728 E:1734 ||| JJ
dominant  ||| S:1734 E:1743 ||| JJ
nature ||| S:1743 E:1749 ||| NN
.  ||| S:1749 E:1751 ||| .
The  ||| S:1751 E:1755 ||| DT
in  ||| S:1755 E:1758 ||| IN
vitro  ||| S:1758 E:1764 ||| JJ
biocompatibility  ||| S:1764 E:1781 ||| NN
of  ||| S:1781 E:1784 ||| IN
the  ||| S:1784 E:1788 ||| DT
bigels  ||| S:1788 E:1795 ||| NN
was  ||| S:1795 E:1799 ||| VBD
checked  ||| S:1799 E:1807 ||| VBN
using  ||| S:1807 E:1813 ||| VBG
human  ||| S:1813 E:1819 ||| JJ
epidermal  ||| S:1819 E:1829 ||| JJ
keratinocyte  ||| S:1829 E:1842 ||| JJ
cell  ||| S:1842 E:1847 ||| NN
line  ||| S:1847 E:1852 ||| NN
( ||| S:1852 E:1853 ||| -LRB-
HaCaT ||| S:1853 E:1858 ||| NNP
) ||| S:1858 E:1859 ||| -RRB-
.  ||| S:1859 E:1861 ||| .
Both  ||| S:1861 E:1866 ||| DT
emulgels  ||| S:1866 E:1875 ||| NN
and  ||| S:1875 E:1879 ||| CC
bigels  ||| S:1879 E:1886 ||| NNS
were  ||| S:1886 E:1891 ||| VBD
biocompatible  ||| S:1891 E:1905 ||| VBN
in  ||| S:1905 E:1908 ||| IN
nature ||| S:1908 E:1914 ||| NN
.  ||| S:1914 E:1916 ||| .
The  ||| S:1916 E:1920 ||| DT
in  ||| S:1920 E:1923 ||| IN
vitro  ||| S:1923 E:1929 ||| JJ
drug  ||| S:1929 E:1934 ||| NN
( ||| S:1934 E:1935 ||| -LRB-
ciprofloxacin ||| S:1935 E:1948 ||| LS
)  ||| S:1948 E:1950 ||| -RRB-
release  ||| S:1950 E:1958 ||| NN
behavior  ||| S:1958 E:1967 ||| NN
indicated  ||| S:1967 E:1977 ||| VBD
non-Fickian  ||| S:1977 E:1989 ||| JJ
diffusion  ||| S:1989 E:1999 ||| NN
of  ||| S:1999 E:2002 ||| IN
the  ||| S:2002 E:2006 ||| DT
drug  ||| S:2006 E:2011 ||| NN
from  ||| S:2011 E:2016 ||| IN
the  ||| S:2016 E:2020 ||| DT
matrices ||| S:2020 E:2028 ||| NN
.  ||| S:2028 E:2030 ||| .
The  ||| S:2030 E:2034 ||| DT
drug  ||| S:2034 E:2039 ||| NN
release  ||| S:2039 E:2047 ||| NN
showed  ||| S:2047 E:2054 ||| VBD
good  ||| S:2054 E:2059 ||| JJ
antimicrobial  ||| S:2059 E:2073 ||| JJ
effect  ||| S:2073 E:2080 ||| NN
against  ||| S:2080 E:2088 ||| IN
Escherichia  ||| S:2088 E:2100 ||| NNP
coli ||| S:2100 E:2104 ||| NNS
.  ||| S:2104 E:2106 ||| .
Based  ||| S:2106 E:2112 ||| VBN
on  ||| S:2112 E:2115 ||| IN
the  ||| S:2115 E:2119 ||| DT
results ||| S:2119 E:2126 ||| NNS
,  ||| S:2126 E:2128 ||| ,
it  ||| S:2128 E:2131 ||| PRP
was  ||| S:2131 E:2135 ||| VBD
concluded  ||| S:2135 E:2145 ||| VBN
that  ||| S:2145 E:2150 ||| IN
the  ||| S:2150 E:2154 ||| DT
developed  ||| S:2154 E:2164 ||| JJ
bigels  ||| S:2164 E:2171 ||| NN
may  ||| S:2171 E:2175 ||| MD
have  ||| S:2175 E:2180 ||| VB
huge  ||| S:2180 E:2185 ||| JJ
potential  ||| S:2185 E:2195 ||| JJ
to  ||| S:2195 E:2198 ||| TO
be  ||| S:2198 E:2201 ||| VB
used  ||| S:2201 E:2206 ||| VBN
as  ||| S:2206 E:2209 ||| IN
alternatives  ||| S:2209 E:2222 ||| NNS
to  ||| S:2222 E:2225 ||| TO
emulgels ||| S:2225 E:2233 ||| VB
.  ||| S:2233 E:2235 ||| .
